Cancer jab can eradicate entire tumours in patients, trial shows

A triple-action cancer jab has shown 'unprecedentedly strong responses' in eradicating entire tumours in patients whose disease was resistant to chemotherapy and immunotherapy. The international trial involved patients across 11 countries with advanced or recurrent cancer.